Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
Apply
Adagrasib, Cetuximab, Cemiplimab
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step